Abstract
BackgroundBCG is recommended as intravesical immunotherapy to reduce the risk of tumor recurrence in patients with non-muscle invasive bladder cancer (NMIBC). Currently, it is unknown whether intravesical BCG application induces...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have